ODTX
Odyssey Therapeutics, Inc.
20.99
+0.99 (+4.95%)
52w low 15.10
29.05 high
42.2% of range
Financial Analysis
| (USD) | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|
| Cash & Equivalents | 241.04M | 52.55M | 59.14M | 41.69M | |
| Current Assets | 248.71M | 192.54M | 135.51M | 190.66M | |
| Net PP&E | 52.77M | 46.73M | 39.47M | 26.01M | |
| Total Assets | 317.15M | 286.52M | 197.44M | 269.79M | |
| Current Liabilities | 22.80M | 22.09M | 28.41M | 26.48M | |
| Total Debt | 42.49M | 34.38M | 31.01M | 27.11M | |
| Total Liabilities | 461.77M | 549.23M | 579.96M | 758.07M | |
| Retained Earnings | -158.17M | -289.09M | -419.49M | -568.14M | |
| Shareholders Equity | -144.62M | -262.71M | -382.53M | -488.28M | |
| Working Capital | 225.91M | 170.45M | 107.09M | 164.18M | |
| Shares Outstanding | 47.17M | 47.17M | 47.17M | 47.17M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
-33.5%